Non-Hodgkin's lymphoma vaccine (CellGenix)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNon-Hodgkin's lymphoma vaccine (CellGenix)
Drug Alias Name非霍奇金淋巴瘤的疫苗 - CellGenix非何杰金淋巴瘤疫苗 - CellGenixIdioVax
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCellgenix Technologie Transfer
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellgenix Technologie Transfer
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A